Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
US Department of Justice
Colorcon
Accenture
Argus Health
Cipla
US Army
Fuji
Boehringer Ingelheim
Cerilliant

Generated: February 25, 2018

DrugPatentWatch Database Preview

THEO-DUR Drug Profile

« Back to Dashboard

Which patents cover Theo-dur, and when can generic versions of Theo-dur launch?

Theo-dur is a drug marketed by Schering and is included in seven NDAs.

The generic ingredient in THEO-DUR is theophylline. There are thirty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the theophylline profile page.

US Patents and Regulatory Information for THEO-DUR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering THEO-DUR theophylline CAPSULE, EXTENDED RELEASE;ORAL 088022-001 Sep 10, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering THEO-DUR theophylline TABLET, EXTENDED RELEASE;ORAL 085328-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering THEO-DUR theophylline CAPSULE, EXTENDED RELEASE;ORAL 087995-001 Sep 10, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering THEO-DUR theophylline TABLET, EXTENDED RELEASE;ORAL 089131-001 Jun 25, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering THEO-DUR theophylline CAPSULE, EXTENDED RELEASE;ORAL 088015-001 Sep 10, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering THEO-DUR theophylline CAPSULE, EXTENDED RELEASE;ORAL 088016-001 Sep 10, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering THEO-DUR theophylline TABLET, EXTENDED RELEASE;ORAL 086998-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering THEO-DUR theophylline TABLET, EXTENDED RELEASE;ORAL 085328-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Chinese Patent Office
Citi
Merck
Express Scripts
Farmers Insurance
US Department of Justice
AstraZeneca
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot